NASDAQ:CNTX

Context Therapeutics Stock Insider Trading

etoro logo Buy CNTX
*Your capital is at risk
$2.05
-0.370 (-15.29%)
At Close: Jun 03, 2026

Context Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 10.84M and sold 0 CNTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 10.84M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 19, 2026
Buy
Stock Option (right to buy)
A-Award
Lehr Martin A.
Chief Executive Officer
CEO / President 815 000
Value: $1.89M
Feb 19, 2026
Buy
Stock Option (right to buy)
A-Award
Chagin Karen Deborah
Chief Medical Officer
Officer 290 000
Value: $672.8K
Feb 19, 2026
Buy
Stock Option (right to buy)
A-Award
Minai-azary Jennifer Lynn
Chief Financial Officer
C-Suite Officer 275 000
Value: $638.0K
Feb 19, 2026
Buy
Stock Option (right to buy)
A-Award
Levit Alex C.
Chief Legal Officer, Corp. Sec
Officer 270 000
Value: $626.4K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Pasternak Andy
Director
Director 138 900
Value: $90.7K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Kantoff Philip W.
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Smith Karen L.
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Stacey Jennifer Evans
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Walker Luke Nathaniel
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
West Linda
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
West Linda
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Walker Luke Nathaniel
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Stacey Jennifer Evans
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Smith Karen L.
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Kantoff Philip W.
Director
Director 123 500
Value: $80.6K
Jun 12, 2025
Buy
Stock Option (right to buy)
A-Award
Pasternak Andy
Director
Director 138 900
Value: $90.7K
Jun 09, 2025
Buy
Common Stock
P-Purchase
Lehr Martin A.
Chief Executive Officer
CEO / President 100 000
Value: $70.1K
Jun 09, 2025
Buy
Common Stock
P-Purchase
Lehr Martin A.
Chief Executive Officer
CEO / President 100 000
Value: $70.1K
Jun 09, 2025
Buy
Stock Option (right to buy)
A-Award
Chagin Karen Deborah
Chief Medical Officer
Officer 153 000
Value: $107.6K
Jun 09, 2025
Buy
Common Stock
J-Other
Chagin Karen Deborah
Officer
Officer 0
Value: $0
Jun 09, 2025
Buy
Stock Option (right to buy)
A-Award
Chagin Karen Deborah
Chief Medical Officer
Officer 153 000
Value: $107.6K
Jun 09, 2025
Buy
Common Stock
J-Other
Chagin Karen Deborah
Officer
Officer 0
Value: $0
Jun 06, 2025
Buy
Common Stock
P-Purchase
Levit Alex C.
Chief Legal Officer, Corp. Sec
Officer 20 000
Value: $11.5K
Jun 06, 2025
Buy
Common Stock
P-Purchase
Levit Alex C.
Chief Legal Officer, Corp. Sec
Officer 20 000
Value: $11.5K
Jun 06, 2025
Buy
Common Stock
P-Purchase
Minai-azary Jennifer Lynn
Chief Financial Officer
C-Suite Officer 40 010
Value: $25.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CONTEXT THERAPEUTICS INC.
Context Therapeutics
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE